Evidence map›Paper›PMID 31215054›Full record

ArticleClinical endocrinology2019

Letter regarding "Prevalence of growth hormone deficiency in previously GH-treated young adults with Prader-Willi syndrome" by Donze et al.

Charlotte Höybye, Maithé Tauber, Moris A Angulo, Urs Eiholzer, Daniel J Driscoll, Suzanne B Cassidy, Antony J Holland, Clinical & Scientific Advisory Board of The International Prader-Willi Syndrome Organisation

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Clinical endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.The Journal of clinical endocrinology and metabolism · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 5 countries.

Charlotte HöybyePatient Area Endocrinology and Nephrology, Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0001-6412-166X
Maithé TauberHôpital des enfants, Centre de référence du Syndrome de Prader-Willi, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Moris A AnguloPediatric Endocrinology, NYU Winthrop Hospital, Mineola, New York.
Urs EiholzerCentre for Pediatric Endocrinology, University of Zürich, Zürich, Switzerland.
Daniel J DriscollChair, IPWSO Clinical & Scientific Advisory Board, University of Florida College of Medicine, Gainesville, Florida.
Suzanne B CassidyPast President IPWSO, Division of Medical Genetics, University of California, San Francisco, California.
Antony J HollandPresident IPWSO, Department of Psychiatry, University of Cambridge, Cambridge, UK.
Clinical & Scientific Advisory Board of The International Prader-Willi Syndrome Organisation
Advisory Board Company (United States) · USCentre Hospitalier Universitaire de Toulouse · FRKarolinska University Hospital · SEUniversity of California, San Francisco · USUniversity of Cambridge · GBUniversity of Zurich · CHWinthrop-University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Human Growth HormonePrader-Willi SyndromeHumansObesityPrevalenceYoung AdultHuman Growth HormoneGH deficiencyGH treatmentPWS adults

Identifiers

PMID31215054
OpenAlexW2951304745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.